Antimüllerian hormone the assessment of the ovarian reserve and the reproductive outcome of the young patient with cancer

Tuesday, April 30, 2013
We discuss the basis for the growing use of AMH in assessment of the ovarian reserve across the lifespan, and its emerging role in assessment before and after cancer treatment.

Read More

Variation in antimüllerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response

Tuesday, April 30, 2013
Antimüllerian hormone varies according to the stage of the menstrual cycle, and the day of blood collection may alter the clinical classification of ovarian response in women seeking fertility therapy.

Read More

Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization

Monday, March 18, 2013
Some genetic polymorphisms are associated with ovarian response to gonadotropin administration and exhibit potential for a pharmacogenetic approach in ovarian stimulation. In contrast, ovarian reserve seems to be independent of gonadotropin variants.

Read More

Predicting fertility with antimullerian hormone Is a cutoff value adequate

Thursday, November 29, 2012
Reflections on "Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study" by Hagen et al.

Read More

Surgical excision of endometriomas and ovarian reserve A systematic review on serum antimullerian hormone level modifications

Thursday, November 29, 2012
Eleven studies have been published on serum AMH levels after surgical excision of ovarian endometriomas. Most of them documented a significant decrease after surgery, thus supporting surgery-related damage to ovarian reserve.

Read More

Effects of resveratrol on growth and function of rat ovarian granulosa cells

Thursday, November 29, 2012
Resveratrol induces cytostatic, but not cytotoxic, effects on granulosa cells, induces a dose-dependent decrease of estradiol production, and reduces vascular endothelial growth factor.

Read More

Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women A prospective cohort study

Thursday, November 29, 2012
Low AMH levels in young healthy women did not predict reduced fecundability. Even after exclusion of women with irregular cycles, the probability of conceiving was reduced in women with high AMH levels.

Read More

Contribution of the rate of change of antimullerian hormone in estimating time to menopause for late reproductive age women

Thursday, November 1, 2012
The rate of change of AMH is an independent predictor of TTM in late reproductive-age women and increased precision of estimates of TTM when included with baseline AMH levels and age.

Read More

Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist

Thursday, November 1, 2012
Circulating AMH declined significantly after gonadal suppression with long-acting GnRH agonist, and AMH recovered to pretreatment levels after discontinuation of GnRH agonist. This is an indication of partial gonadotropin-dependence of AMH.

Read More

Interpreting human follicular recruitment and antimullerian hormone concentrations throughout life

Thursday, November 1, 2012
The relationships between primordial follicles, follicular recruitment, and circulating AMH are dynamic, reflecting the different stages of the reproductive lifespan. This article discusses these relationships and their clinical implications.

Read More

Limitations and pitfalls of antimüllerian hormone measurements

Thursday, September 27, 2012
Reflections on "High frequency of discordance between antimullerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers"

Read More

High frequency of discordance between antimullerian hormone and follicle stimulating hormone levels in serum from estradiol confirmed days 2 to 4 of the menstrual cycle from 5354 women in US…

Thursday, September 27, 2012
Frequent discordance was observed between antimullerian hormone and follicle-stimulating hormone, which increased with age in serum from 5,354 women in estradiol-confirmed cycle days 2 to 4.

Read More

A characterization of the relationship of ovarian reserve markers with age

Monday, June 4, 2012
Antral follicle count and antimullerian hormone rate of decline is similar to histologic oocyte loss.

Read More

Androgens and antimüllerian hormone in mothers with polycystic ovary syndrome and their newborns

Thursday, May 31, 2012
In mothers with polycystic ovary syndrome, metformin had no impact on antim€ullerian hormone or androgen levels but increased the free testosterone index in the umbilical vein of boys.

Read More

Evaluation of the ovarian reserve in women transplanted with frozen and thawed ovarian cortical tissue

Thursday, May 31, 2012
The follicle pool in transplanted frozen/thawed ovarian tissue is low compared with normal ovaries, and reduced follicular selection may explain these women’s poor reproductive outcomes in assisted reproduction.

Read More

Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B

Friday, May 4, 2012
This report describes the peripheral levels of inhibin B and antimullerian hormone in boys during peripuberty and in patients with congenital hypogonadotropic hypogonadism.

Read More

Translate »